[EN] NOVEL GLP-1 RECEPTOR AGONISTS WITH CHOLESTEROL EFFLUX ACTIVITY<br/>[FR] NOUVEAUX AGONISTES DES RÉCEPTEURS À LA GLP-1 AVEC ACTIVITÉ D'EFFLUX DU CHOLESTÉROL
申请人:NOVO NORDISK AS
公开号:WO2014096179A1
公开(公告)日:2014-06-26
The present invention provides novel glucagon-like protein-1(GLP-1) receptor agonist compounds that promote cholesterol efflux. The present invention also provides compositions comprising the novel glucagon-like protein-1(GLP-1) receptor agonist compounds, and relates to the use of said compounds in therapy, to methods of treatment comprising administration of said compounds to patients, and to the use of said compounds in the manufacture of medicaments.